5 Innovators to Watch on 'New to The Street' Tonight: Focus on Synergy CHC, Health In Tech, and More

Investors, fasten your seatbelts! Tonight’s New to The Street episode (#655) is a can’t-miss ride, featuring five disruptive companies poised to make waves in health, tech, and beyond. Let’s break down the opportunities—and the risks—before you.

Synergy CHC (NASDAQ: SNYR): Health & Wellness’s Next Big Thing?

Starting with Synergy CHC, the health and wellness giant behind the viral Focus Factor® brain supplement and Flat Tummy Tea®, this company has been on a roll. But let’s cut through the hype with the numbers:

• Stock Price: $3.02 (as of Feb 2025), with a market cap of $32M.
• Profitability: 7th consecutive quarter of profitability, but revenue fell 34% YoY in Q3 2024 due to retailer de-inventorying. Gross margins remain healthy at 67.2%, though down from 72% in 2023.
• Upcoming Catalyst: Q1 2025 earnings are due May 15—a must-watch for investors. CEO Jack Ross and CFO Jaime Fickett will discuss whether revenue declines have stabilized and how the IPO (which raised $8.4M in October 2024) is funding growth.

Cramer’s Take: This stock is a “buy the dip” candidate if earnings show stabilization. But be wary of execution risks—retailers are fickle, and the wellness market is crowded.

Health In Tech (NASDAQ: HIT): The Insurtech Disruptor

Next up: Health In Tech, the insurtech innovator making waves with AI-driven health plans for employers and brokers. The numbers here are eye-popping:

• Q1 2025 Revenue: $8M (+56% YoY), with income before taxes tripling to $0.7M.
• Growth Drivers: A partnership with DialCare to integrate telehealth services and a beta launch of an AI underwriting platform (set for full rollout by Q3).
• Cash Position: $7.6M as of March 2025—healthy liquidity to fuel expansion.

Cramer’s Take: This is a “buy now, hold forever” stock. With AI and telehealth reshaping insurance, HIT’s momentum is undeniable.

LightPath Technologies (NASDAQ: LPTH): Photonics Powerhouse

LightPath Technologies is the unsung hero of advanced photonics, serving defense, aerospace, and telecom sectors. Key points:

• Defense Contracts: Secured a $4.9M follow-on order for infrared assemblies and a $2.2M U.S. Navy SPEIR program win.
• Acquisition Boost: The $15M+ G5 Infrared acquisition (Feb 2025) adds cooled infrared cameras and thin-film tech, targeting 15% EBITDA margins.
• Stock Performance: Up 1.24% in May 2025, with a 5-year return of 278%—but volatility remains due to margin pressures.

Cramer’s Take: Buy the dips here. Defense spending is up, and LightPath’s BlackDiamond™ glass (a germanium substitute) is a game-changer amid supply chain wars.

Roadzen (NASDAQ: RDZN): AI’s Auto Insurance Revolution

Roadzen is the AI-driven auto insurance disruptor, offering real-time claims processing and connected vehicle tech. While financials are sparse, the vision is bold:

• Market Opportunity: The $300B auto insurance market is ripe for tech-driven efficiency. Roadzen’s AI could carve out a dominant niche.
• Risk: No stock price or financials provided—investors are flying blind.

Cramer’s Take: Hold off until more data emerges. The idea is solid, but visibility is lacking.

Skip Barber Racing School: Betting on Branded Experiences

The legendary Skip Barber Racing School is expanding into e-sports and branded motorsport events—a smart pivot to younger audiences. However:

• No Public Stock: Skip Barber isn’t listed, so individual investors are locked out.
• Growth Potential: If they go public, this could be a diamond in the rough.

Conclusion: Buy the Innovators, but Do Your Homework

Tonight’s episode highlights three clear buys:
1. Health In Tech (HIT): 56% revenue growth and AI-powered disruption make it a must-own.
2. LightPath (LPTH): Defense contracts and the G5 acquisition position it to capitalize on geopolitical tensions.
3. Synergy CHC (SNYR): A “wait for earnings” call—its wellness brands are iconic, but execution is key.

Avoid Roadzen until financials emerge, and keep an eye on Skip Barber’s potential IPO.

In this era of disruption, these companies are rewriting the rules. But remember: invest in the numbers, not the hype.

Final Tip: Tune into the episode tonight at 6:30 PM EST on Bloomberg! The Street’s next wave starts here.